SARS-CoV-2 and the safety of blood donations: Time for a brave revision?
作者信息
Focosi Daniele, Franchini Massimo
机构信息
North-Western Tuscany Blood Bank, Pisa University Hospital, Pisa, Italy.
Department of Hematology and Transfusion Medicine, Carlo Poma Hospital, Mantua, Italy.
出版信息
Transfusion. 2022 Mar;62(3):717-719. doi: 10.1111/trf.16818.
Abstract
摘要
相似文献
1
SARS-CoV-2 and the safety of blood donations: Time for a brave revision?严重急性呼吸综合征冠状病毒2（SARS-CoV-2）与献血安全：是时候进行大胆修订了吗？
Transfusion. 2022 Mar;62(3):717-719. doi: 10.1111/trf.16818.
2
Estimated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020-May 2021.根据 2020 年 7 月至 2021 年 5 月的献血样本，估计美国感染和疫苗引起的 SARS-CoV-2 血清流行率。
JAMA. 2021 Oct 12;326(14):1400-1409. doi: 10.1001/jama.2021.15161.
3
Minipool testing for SARS-CoV-2 RNA in United States blood donors.美国献血者中 SARS-CoV-2 RNA 的微池检测。
Transfusion. 2021 Aug;61(8):2384-2391. doi: 10.1111/trf.16511. Epub 2021 May 27.
4
Serologic Testing of US Blood Donations to Identify Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Reactive Antibodies: December 2019-January 2020.美国献血者血清学检测以鉴定严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）反应性抗体：2019 年 12 月-2020 年 1 月。
Clin Infect Dis. 2021 Jun 15;72(12):e1004-e1009. doi: 10.1093/cid/ciaa1785.
5
Low rate of RNAemia in blood donations collected during the first wave of COVID-19 in France.法国第一波新冠疫情期间采集的献血中RNA血症发生率较低。
Transfusion. 2022 Mar;62(3):633-640. doi: 10.1111/trf.16812. Epub 2022 Feb 9.
6
Low Prevalence of Antibodies to SARS-CoV-2 and Undetectable Viral Load in Seropositive Blood Donors from South-Eastern Italy.意大利东南部血清阳性献血者中 SARS-CoV-2 抗体的低流行率和无法检测到的病毒载量。
Acta Haematol. 2021;144(5):580-584. doi: 10.1159/000515258. Epub 2021 Apr 20.
7
Seroprevalence of SARS-CoV-2 among blood donors: A practical serosurveillance tool for COVID-19.献血者中SARS-CoV-2的血清流行率：一种用于COVID-19的实用血清学监测工具。
Transfus Clin Biol. 2022 May;29(2):182-183. doi: 10.1016/j.tracli.2021.11.005. Epub 2021 Dec 15.
8
SARS-CoV-2 antibody kinetics in blood donors with a previously positive SARS-CoV-2 antibody test within a seroprevalence survey.在一项血清流行率调查中，对先前 SARS-CoV-2 抗体检测呈阳性的献血者的 SARS-CoV-2 抗体动力学进行研究。
J Med Virol. 2022 Apr;94(4):1711-1716. doi: 10.1002/jmv.27486. Epub 2021 Dec 8.
9
Estimation of SARS-CoV-2 Infection Fatality Rate by Real-time Antibody Screening of Blood Donors.通过实时献血者抗体筛查估计 SARS-CoV-2 感染病死率。
Clin Infect Dis. 2021 Jan 27;72(2):249-253. doi: 10.1093/cid/ciaa849.
10
SARS-CoV-2 serological cross-reactivity testing in Brazilian blood donors, October-December, 2019.2019年10月至12月巴西献血者中新型冠状病毒2型血清学交叉反应性检测
J Infect. 2022 Feb;84(2):e1-e2. doi: 10.1016/j.jinf.2021.12.041. Epub 2022 Jan 1.
引用本文的文献
1
Investigating Blood Donors With Postdonation Respiratory Tract Symptoms During the Wild-Type, Delta, and Omicron Waves of the Coronavirus Disease 2019 Pandemic in England.在英国2019冠状病毒病大流行的野生型、德尔塔和奥密克戎毒株流行期间，对献血后出现呼吸道症状的献血者进行调查。
Open Forum Infect Dis. 2023 Oct 5;10(10):ofad499. doi: 10.1093/ofid/ofad499. eCollection 2023 Oct.
本文引用的文献
1
No evidence of SARS-CoV-2 transmission through transfusion of human blood products: A systematic review.无严重急性呼吸综合征冠状病毒2通过输注人血制品传播的证据：一项系统评价。
EJHaem. 2021 Jul 19;2(3):601-606. doi: 10.1002/jha2.263. eCollection 2021 Aug.
Zotero 插件